Skip to main content
. 2020 Jun 18;10:982. doi: 10.3389/fonc.2020.00982

Figure 6.

Figure 6

Correlation between the circ-PNN and CRC. (A) The relative expression of serum exosomal circ-PNN (relative to β-actin) in patients with CRC (n = 88) and healthy controls (n = 88) determined using RT-qPCR assay in the training set, ***P < 0.001. (B) ROC curve analysis for the determination of the diagnostic performance of circ-PNN in the training set. (C) The relative expression of serum exosomal circ-PNN (relative to β-actin) in patients with CRC (n = 58) and control individuals (n = 58) determined using RT-qPCR assay in the validation set, ***P < 0.001. (D) ROC curves for the determination of the diagnostic performance of circ-PNN in the validation set. (E) ROC curve showing the capability of serum exosomal circ-PNN in distinguishing patients with early-stage CRC from normal healthy individuals. (F) ROC curve showing the capability of serum exosomal circ-PNN in distinguishing patients with Lymph node metastasis.